Q1 2022 Kane Biotech Inc Earnings Call Transcript
Good day, and thank you for standing by, and welcome to the Kane Biotech Q1 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded. (Operator Instructions)
I would now like to hand the conference over to your host today, Nicole Sendey, Kane Biotech Investor Relations and Public Relations Specialist. You may begin.
Thank you. Good afternoon, and welcome, everyone, to Kane Biotech's quarterly earnings conference call. We are delighted to have you join us today. This call will cover Kane's financial and operating results for the first quarter of 2022 along with a discussion of some of our recent highlights and goals for 2022 and beyond. Following our prepared remarks, we will open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.
Before we begin our formal remarks, I would like to remind everyone that some of the statements on this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |